Objective:
To investigate the expression of long-chain non-coding RNA MINCR (LncRNAMINCR)
and Cyclin-Dependent Kinase 2 (CDK2) mRNA in primary hepatocellular carcinoma, and to
analyze the relationship between its expression and clinical pathological parameters and prognosis of
hepatocellular carcinoma.
Methods:
Seventy-five surgically resected primary hepatocellular carcinoma tissues and paracancerous
tissues were selected. Real-time PCR was used to detect the expression of LncRNA-MINCR and CDK2
mRNA in hepatocellular carcinoma tissues and adjacent tissues. The relationship of clinicopathological
parameters and prognosis between hepatocellular carcinoma and LncRNA-MINCR and CDK2 mRNA
were analyzed. Pearson correlation coefficient describes the correlation between LncRNA-MINCR and
CDK2 mRNA.
Results:
The expression of LncRNA-MINCR and CDK2 mRNA in primary hepatocellular carcinoma
tissues was higher than that in the adjacent tissues [(5.51±0.62) vs (1.62±0.51), (4.52±0.73) vs (1.85±0.95),
P<0.05]. The expression of LncRNA-MINCR in the primary hepatocellular carcinoma group was
positively correlated with CDK2 mRNA (r=0.352, P<0.05), and the expression of LncRNA-MINCR in the
paracancerous tissue group was not correlated with CDK2 mRNA (r=0.024, P>0.05). LncRNA-MINCR
expression was associated with TNM staging, lymph node metastasis, and cirrhosis (P<0.05). CDK2
mRNA expression was associated with tumor diameter, TNM stage, lymph node metastasis, and serum
alpha-fetoprotein levels (P<0.05). The 3-year survival rate of patients with high expression of LncRNAMINCR
was lower than that of LncRNA-MINCR low expression group [53.49% vs 77.38%, 2=13.024,
P<0.05). The 3-year survival rate of patients with high CDK2 mRNA expression was lower than that of
CDK2 mRNA low expression group [51.29] % vs 80.38%, 2 = 10.15, P < 0.05].
Conclusion:
The expression of LncRNA-MINCR and CDK2 mRNA in primary hepatocellular carcinoma
tissues increased significantly. The two play a synergistic role in the invasion, invasion and metastasis of
hepatocarcinoma cells. High expression of LncRNA-MINCR and CDK2 mRNA indicates poor prognosis
in patients with hepatocellular carcinoma.